Biotech
Scope
Date
~
-
Bio & Pharma
Korean biopharma, biotech companies scale up as sales balloon
South Korea’s biotech and biopharmaceutical companies are growing big with their sales rising above 1 trillion won ($796 million) last year on...
Feb 07, 2023 (Gmt+09:00)
-
Bio & Pharma
South Korean biotech firms tap Middle East as next key market
South Korean biotech companies are speeding up their foray into the Middle East to tap oil money as they seek new growth engines beyond fossil fuels...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Nanodrug maker CEO calls on Yoon government for deregulation
South Korean startups won four out of the 23 Best of Innovation awards at CES 2023, the world’s largest tech show last month. Among the winner...
Feb 03, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem completes acquisition of US biotech firm AVEO
LG Chem Ltd. is set to complete its $571 million purchase of the US biotech firm AVEO Pharmaceuticals Inc. on Friday, which would strengthen its ant...
Jan 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Medipost completes first dose of Cartistem in phase 3 clinical trials in Japan
South Korea's stem cell research company Medipost Co. said on Monday that it has completed the administration of Cartistem, a stem cell treatment fo...
Jan 17, 2023 (Gmt+09:00)
-
Chemical Industry
Solvay named preferred bidder to buy Solus Biotech
Belgian chemicals maker Solvay S.A. has been selected as the preferred bidder to acquire South Korean biomaterials maker Solus Biotech, according to...
Dec 29, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotechs target US labs to speed up regulatory approval for tests
South Korean molecular diagnostics companies are increasingly buying high-quality laboratories in the US that meet federal regulatory standards in a...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
Medipost's Cartistem shows effects on patellar cartilage defect patients
Medipost's knee osteoarthritis treatment Cartistem has been mentioned in a renowned international journal, showing that it is effective even in pati...
Dec 27, 2022 (Gmt+09:00)
-
Private equity
BASF, ADM join race to buy Korean ceramide maker Solus Biotech
BASF SE, the world’s largest chemical producer, US food processing giant ADM Co. and two other global companies have joined the race to acquir...
Dec 27, 2022 (Gmt+09:00)
-
Venture capital
Korea’s big bio startups to launch $39 mn investment fund
South Korea’s four leading biotech firms plan to launch an investment fund of up to 50 billion won ($39 million) to support smaller domestic b...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
CENYX Biotech, developing treatment for brain damage with ROS-scavenging, nano-sized heavy metals
When severe brain diseases such as cerebral infarction or cerebral hemorrhage occur, the blood-brain barrier (BBB) in our body no longer functions p...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
ToolGen, ANLBIO to jointly develop progeria treatments
South Korea's two biotech startups ToolGen Incorporated and ANLBIO on Tuesday signed a joint research and development agreement for developing proge...
Dec 21, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korean biotech firm Noul signs MOU with disease center of Ghana
South Korea's Medical diagnostics company Noul Co., Ltd. said on Monday that it has signed a memorandum of understanding with the Ghana Infectious D...
Dec 12, 2022 (Gmt+09:00)
-
Bio & Pharma
MDimune signs research agreement with Australian National University
MDimune, a South Korean biotech company, said on Wednesday that it had signed an agreement with the Clear Vision Research (CVR) Lab, a research grou...
Dec 07, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharmaceutical relocates US research center from Seattle to Boston
JW Pharmaceutical announced on Wednesday that it has relocated its US research center to Boston from San Diego. JW Theriac was first establishe...
Nov 23, 2022 (Gmt+09:00)
-
Chemical Industry
Samyang transitions to white biotech with S.Korea’s first isosorbide plant
Samyang Group, a diversified conglomerate, has long focused on the chemicals and foodstuffs sectors. While adding to its existing chemicals bus...
Nov 17, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea’s Peak Bio makes Nasdaq debut via SPAC deal with Ignyte
Peak Bio Co., a South Korean biopharmaceutical company, is debuting on the Nasdaq through a merger with US blank cheque company Ignyte Acquisition C...
Oct 28, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Korea's LG Chem buys Nasdaq-listed biotech firm AVEO for $566 mn
South Korea’s chemicals giant LG Chem Ltd. announced on Oct. 18 that it will acquire AVEO Pharmaceuticals Inc., a Nasdaq-listed US biotech fir...
Oct 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Moderna to stay ahead in mRNA technology: CSO Melissa Moore
CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...
Oct 14, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio suffers as weak won lifts global clinical trial costs
South Korean biopharmaceutical firms are facing challenges in clinical trials overseas alongside the rising Korean won to the US dollar exchange rat...
Oct 14, 2022 (Gmt+09:00)
-
Bio & Pharma
Sanofi, Korean biotech Lemonex ink material transfer agreement
South Korean biotech Lemonex Inc. has signed a material transfer agreement (MTA) with global pharmaceutical giant Sanofi S.A. to use the Korean bi...
Sep 14, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio firms look to pills, patches for people who fear needles
Getting shots of a drug or vaccine over a long period is not easy for many people.That's probably why global biopharmaceutical companies and biotech...
Aug 24, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea's SD Biosensor to supply diagnostics kits to Japan in H2
SD Biosensor Inc., South Korea’s leading in-vitro diagnostics company, has signed an agreement to supply its COVID-19 self-test kits and other...
Aug 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics, Samsung C&T extends investment in US biotech firms
The Life Science Fund, jointly launched by Samsung Biologics and Samsung C&T Corp., announced Wednesday it invested $15 million in US biotech fi...
Aug 17, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Harim seeks Genofocus purchase to enter biotechnology business
Harim Co., South Korea’s top poultry processing company, is seeking to acquire Genofocus Inc., a Kosdaq-listed industrial and pharmaceutical e...
Aug 08, 2022 (Gmt+09:00)
-
Corporate investment
SK to build first chip packaging plant in US with $22 bn investment
WASHINGTON DC – SK Group, South Korea’s second-largest conglomerate, said on Wednesday it will build its first memory chip packaging fac...
Jul 27, 2022 (Gmt+09:00)
-
Private equity
SK Square makes its first exit seeking new target firms
South Korean investment firm SK Square Co. has sold all of its shares in Korean biotech NanoEntek Inc., a 28.4% stake, for 58 billion won ($44.3 mil...
Jul 20, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Samsung Biologics eye record-high annual sales
South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...
Jul 08, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)